(Q46900610)

26 December 2017

title

SPARCL: the glimmer of statins for stroke risk reduction (English)

1 reference

26 December 2017

1

Annemarie Armani

1 reference

26 December 2017

Peter P Toth

2

1 reference

26 December 2017

publication date

1 November 2007

1 reference

26 December 2017

Current Atherosclerosis Reports

published in

1 reference

26 December 2017

volume

9

1 reference

26 December 2017

page(s)

347-351

1 reference

26 December 2017

issue

5

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1007/s11883-007-0044-1

exact match

0 references

cites work

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

1 reference

https://api.crossref.org/works/10.1007%2FS11883-007-0044-1

Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-007-0044-1

Neuroprotective properties of statins in cerebral ischemia and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-007-0044-1

Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-007-0044-1

Targeting eNOS for stroke protection

21 January 2018

1 reference

12 December 2020

Biological basis for statin therapy in stroke prevention

1 reference

12 December 2020

High-dose atorvastatin after stroke or transient ischemic attack

1 reference

12 December 2020

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

12 December 2020

Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration

1 reference

12 December 2020

Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke...

1 reference

12 December 2020

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

12 December 2020

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

1 reference

12 December 2020

Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis

1 reference

12 December 2020

Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability

1 reference

12 December 2020

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase

1 reference

12 December 2020

Risk factors and 20-year stroke mortality in men and women in the Renfrew/Paisley study in Scotland

1 reference

12 December 2020

Ten-year risk of first recurrent stroke and disability after first-ever stroke in the Perth Community Stroke Study.

1 reference

12 December 2020

Stroke mortality and the apoB/apoA-I ratio: results of the AMORIS prospective study

1 reference

12 December 2020

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

1 reference

12 December 2020

Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

12 December 2020

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

1 reference

12 December 2020

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

12 December 2020

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

12 December 2020

Pravastatin Therapy and the Risk of Stroke

1 reference

12 December 2020

Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program

1 reference

12 December 2020

Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study

1 reference

12 December 2020

Clofibrate and niacin in coronary heart disease

1 reference

12 December 2020

Statins for stroke prevention: disappointment and hope

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

12 December 2020

Recurrent stroke risk is higher than cardiac event risk after initial stroke/transient ischemic attack.

1 reference

12 December 2020

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.

1 reference

12 December 2020

Occurrence of secondary ischemic events among persons with atherosclerotic vascular disease

1 reference

12 December 2020

Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial

1 reference

12 December 2020

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

12 December 2020

Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S)

1 reference

12 December 2020

Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors

1 reference

12 December 2020

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

1 reference

12 December 2020

Low concentration of serum total cholesterol is associated with multifocal signal loss lesions on gradient-echo magnetic resonance imaging: analysis of risk factors for multifocal signal loss lesions

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

1 reference

12 December 2020

Stroke prevention therapy beyond antithrombotics: unifying mechanisms in ischemic stroke pathogenesis and implications for therapy: an invited review

1 reference

12 December 2020

Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study

1 reference

12 December 2020

10.1007/S11883-007-0044-1

Identifiers

DOI

1 reference

26 December 2017

PubMed ID

18001616

1 reference

26 December 2017